LOGIN  |  REGISTER
Amneal Pharmaceuticals

Humana Healthy Horizons Commits $500K to Improve Health of Louisianians

April 25, 2024 | Last Trade: US$257.83 8.49 -3.19
  • 24 nonprofits to receive investments to address urgent health care needs
  • Investments are aimed at addressing maternal health, food insecurity, chronic condition management, behavioral health and more
  • A portion of the grants to help expand and diversify the health care workforce through partnerships with colleges and universities

BATON ROUGE, La. / Apr 25, 2024 / Business Wire / Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced today that it will invest $500,000 in 2024 in support of community organizations across Louisiana.

The investment dollars have been disbursed to 24 nonprofit organizations that share the company’s passion for overcoming public health challenges and improving the health and well-being of Louisianians.

“Partnering with community-based organizations and local institutions is central to our ‘human care’ ethos. We believe in reaching our members where they are to best address their health-related social needs and encourage their best health,” said Lori Dunne, President, Humana Healthy Horizons – Louisiana.

The investments, given to community partners across the entire state, are helping parents, families and individuals in need – including new mothers and children – with health and wellness, education, food security and more. This year, a portion of the grants are dedicated to expanding and diversifying the health care workforce through partnerships with institutions of higher education, to include historically Black colleges and universities (HBCUs).

“Humana’s 2024 support will provide critically important assistance to Xavier's Physician Assistant (P.A.) and Pre-Med programs, as well as our Career Services Office and ‘Give.Love.Xavier. 2024’ Campaign,” said Jeff Hale, Director of Corporate and Foundation Relations at Xavier University. “I am particularly impressed with this spread of 2024 support, which encompasses student aid (in two vital health sciences programs), annual fund (the day-to-day lifeblood of private universities such as Xavier), and career readiness, the signpost at the intersection of university life and the business/professional world.”

Loyola University New Orleans officials also see the grant providing significant value for their health care programs.

“This funding will help Loyola support diverse students of the Nurse-Midwifery education program to complete their education,” said Michelle Collins, Dean of the College of Nursing and Health at Loyola University New Orleans. “Certified nurse-midwives are a solution for the abysmal perinatal outcomes in Louisiana. Via this financial support, new certified nurse-midwives will be added to the healthcare landscape of Louisiana, which will benefit mothers and babies statewide.”

Recipients of the grants, ranging from $5,000-50,000 each, include the following:

  • 318 Foundation
  • Birthmark Doula Collective
  • Children’s Hospital of New Orleans
  • Community Foundation of North Louisiana
  • Delgado
  • DePaul Community Health Center
  • Dillard University School of Public Health Sciences
  • Fathers on a Mission
  • Grambling State University
  • Healthy BR
  • Institute for Women and Ethnic Studies
  • Louisiana State University at Eunice
  • Loyola University New Orleans, College of Nursing and Health
  • March of Dimes New Orleans
  • Mary Bird Perkins
  • MedCamps
  • New Orleans East Hospital
  • NOELA
  • Ochsner LSU Health Shreveport PROTECT Program
  • Our Lady of the Lake Children’s Hospital
  • Peer Initiative
  • Southern University New Orleans
  • The Three O’Clock Project
  • Xavier University of Louisiana

Humana has invested more than $1.6 million in support of more than 50 nonprofits in Louisiana since launching its Humana Healthy Horizons brand in 2022. Additionally, the Humana Foundation has invested $1.7 million in organizations impacting mental health and food insecurity in Louisiana and other geographies.

About Humana Healthy Horizons

Humana manages Medicaid benefits for nearly 1.2 million members nationally under the Humana Healthy Horizons™ brand, which reflects our expertise in managing complex populations, our commitment to creating solutions that lead to a better quality of life for our members, and our efforts to deliver human care that makes the healthcare experience easier, more personalized and more caring.

During more than two decades of serving people with Medicaid, Humana and Humana Healthy Horizons have developed a wide range of capabilities to serve children, parents, childless adults, and beneficiaries that are aged, blind or disabled. We integrate physical health, behavioral health, pharmacy, long-term care, and social services for a whole-person approach to improve the health and well-being of our members and the communities we serve.

Humana Healthy Horizons serves Medicaid enrollees through the following programs:

  • Medicaid Managed Care (MMC)
  • Managed Long Term Services and Supports (MLTSS)
  • Medicare Advantage Dual-eligible Special Needs Plans (D-SNPs) and Medicare Prescription Drug Plans (PDPs)

Humana Healthy Horizons is a Medicaid Product offered by affiliates of Humana Inc.

About Humana

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

Recursion

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB